{"id":56753,"date":"2026-04-07T15:05:30","date_gmt":"2026-04-07T15:05:30","guid":{"rendered":"https:\/\/www.europesays.com\/dk\/56753\/"},"modified":"2026-04-07T15:05:30","modified_gmt":"2026-04-07T15:05:30","slug":"novo-nordisk-launches-higher-dose-wegovy-in-the-united-states","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/dk\/56753\/","title":{"rendered":"Novo Nordisk launches higher-dose Wegovy in the United States"},"content":{"rendered":"\n<p class=\"yf-1fy9kyt\">April 7 (Reuters) &#8211; Novo Nordisk said on Tuesday that it has made \u200ca higher-dose version of its \u200cblockbuster weight-loss drug Wegovy available across the United \u200bStates.<\/p>\n<p class=\"yf-1fy9kyt\">The 7.2-milligram dose, branded as Wegovy HD, gained approval under the FDA Commissioner&#8217;s National Priority Review Voucher program last \u200cmonth.<\/p>\n<p class=\"yf-1fy9kyt\">Before the \u2060approval, the highest authorized dose of the injectable Wegovy for \u2060weight loss was 2.4 mg.<\/p>\n<p class=\"yf-1fy9kyt\">The company said the higher-dose Wegovy will be available \u200bthrough U.S. \u200bpharmacies, NovoCare \u200bPharmacy and select \u200ctelehealth providers.<\/p>\n<p class=\"yf-1fy9kyt\">Cash-paying adults prescribed Wegovy HD can expect to pay $399 per month, while commercially insured patients may pay as little as $25 per month using the Wegovy \u200csavings offer, Novo \u200bsaid.<\/p>\n<p class=\"yf-1fy9kyt\">Last month, Novo said \u200bit plans \u200bto launch a discounted subscription \u200cplan for U.S. Wegovy \u200bpatients paying \u200bfor the drug themselves, offering steep discounts to regain ground ceded to \u200bEli \u200cLilly in the obesity-drug market.<\/p>\n<p class=\"yf-1fy9kyt\">(Reporting by \u200bSneha S K in Bengaluru; Editing \u200bby Tasim Zahid)<\/p>\n","protected":false},"excerpt":{"rendered":"April 7 (Reuters) &#8211; Novo Nordisk said on Tuesday that it has made \u200ca higher-dose version of its&hellip;\n","protected":false},"author":2,"featured_media":56754,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[271],"tags":[272,7124,24895],"class_list":["post-56753","post","type-post","status-publish","format-standard","has-post-thumbnail","category-novo-nordisk","tag-novo-nordisk","tag-the-united-states","tag-wegovy-hd"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@dk\/116364045648447360","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/56753","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/comments?post=56753"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/56753\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media\/56754"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media?parent=56753"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/categories?post=56753"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/tags?post=56753"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}